Evercore ISI Group Maintains Outperform on Abbott Laboratories, Lowers Price Target to $120
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar maintains an Outperform rating on Abbott Laboratories (NYSE:ABT) but lowers the price target from $125 to $120.
July 02, 2024 | 2:55 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Evercore ISI Group analyst Vijay Kumar maintains an Outperform rating on Abbott Laboratories but lowers the price target from $125 to $120.
The Outperform rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100